Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts124/v4/42/35/9c/42359c72-cf8e-73be-f080-8a045d2317d2/mza_10323691147012776674.jpg/600x600bb.jpg
Medspectives
Arvind Rajan
38 episodes
5 days ago
Medspectives is a series featuring conversations with health professionals from diverse backgrounds around the world, with the goal of understanding their unique viewpoints in social topics, common issues they see in the field, and anecdotes that have defined their career life. Medspectives is currently dedicated to covering the viewpoints and opinions of healthcare workers around the world in addressing the COVID-19 pandemic, as well as the struggles they are facing. Hosted by Arvind Rajan.
Show more...
Medicine
Health & Fitness
RSS
All content for Medspectives is the property of Arvind Rajan and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Medspectives is a series featuring conversations with health professionals from diverse backgrounds around the world, with the goal of understanding their unique viewpoints in social topics, common issues they see in the field, and anecdotes that have defined their career life. Medspectives is currently dedicated to covering the viewpoints and opinions of healthcare workers around the world in addressing the COVID-19 pandemic, as well as the struggles they are facing. Hosted by Arvind Rajan.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode400/7171149/7171149-1633972524446-efa99b918f48f.jpg
The Nefarious History of the Opioid Crisis and A New Drug Platform to Address It with Dr. Mike Presti, SafeRx
Medspectives
44 minutes 19 seconds
4 years ago
The Nefarious History of the Opioid Crisis and A New Drug Platform to Address It with Dr. Mike Presti, SafeRx

I know it's been about a month since our last episode, but we're back with a super interesting talk about one of the biggest problems in medicine right now: the opioid crisis. Opioids, like hydrocodone and oxycodone, are used to treat patients with severe pain, whether it be post-surgery, cancer-related pain, and other similar instances. However, they trigger the release of endorphins, the brain's way of making you feel good, and this sensation can be highly addictive, leading to abuse of these drugs. Opioid abuse affects countless people across the world and costs the US hundreds of billions of dollars in costs associated with healthcare, criminal justice, and the foster system. One particularly dangerous type of abuse is consuming alcohol with opioids, which can cause respiratory distress, and ultimately death relatively quickly. While patients are advised not to take alcohol with opioids, 30-80 percent of them still do, and it is this issue that our guest Dr. Mike Presti hopes to address. Dr. Presti is a Mayo-clinic trained neurologist and CEO of SafeRx, a company using its unique alcohol-resistant opioids platform to reduce the risk of prescription opioid overdose. I don't want to give away too much in this intro, but I think this simple drug concept has the potential to revolutionize the field and prevent alcohol-related opioid abuse. It is currently in its early stages, and if you'd like to learn more or potentially  be a part of the company, check it out at investinsaferx.com

Medspectives
Medspectives is a series featuring conversations with health professionals from diverse backgrounds around the world, with the goal of understanding their unique viewpoints in social topics, common issues they see in the field, and anecdotes that have defined their career life. Medspectives is currently dedicated to covering the viewpoints and opinions of healthcare workers around the world in addressing the COVID-19 pandemic, as well as the struggles they are facing. Hosted by Arvind Rajan.